Arbutus Biopharma (ABUS) Q2 2024 Earnings

May 2Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.12
-0.11
-0.11
-0.1

Details

Expected EPS
-0.11
Actual EPS
-0.1
Surprise EPS
0.01
Surprise Percent
+9.09%

Description

⁨Arbutus Biopharma⁩ (⁦ABUS⁩) has reported earnings of ⁦-0.1⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts